|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 | |||
| A61P 27/16 |
| (11) | Number of the document | 2773758 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12806730.3 |
| Date of filing the European patent application | 2012-11-01 | |
| (97) | Date of publication of the European application | 2014-09-10 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/062894 |
| Date | 2012-11-01 |
| (87) | Number | WO 2013/067076 |
| Date | 2013-05-10 |
| (30) | Number | Date | Country code |
| 201161554982 P | 2011-11-03 | US | |
| 201261663627 P | 2012-06-25 | US |
| (72) |
FEINSTEIN, Elena, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
|
| (54) | COMPOSITIONS FOR USE IN NEUROPROTECTION |
| COMPOSITIONS FOR USE IN NEUROPROTECTION |